UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044418 |
|---|---|
| Receipt number | R000050740 |
| Scientific Title | A prospective study of the optimal depth of anesthesia for remimazolam anesthesia |
| Date of disclosure of the study information | 2021/06/03 |
| Last modified on | 2021/06/03 19:26:55 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A prospective study of the optimal depth of anesthesia for remimazolam anesthesia
Acronym
A prospective study on the depth of anesthesia for remimazolam anesthesia
Scientific Title
A prospective study of the optimal depth of anesthesia for remimazolam anesthesia
Scientific Title:Acronym
A prospective study on the depth of anesthesia for remimazolam anesthesia
Region
| Japan |
Condition
Condition
Not specified
Classification by specialty
| Anesthesiology | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study was to analyze the EEG changes induced by the general anesthetic remimazolam and to verify whether a general-purpose anesthesia depth monitor based on EEG changes can be used appropriately.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
EEG changes during remimazolam anesthesia
Key secondary outcomes
The validity of a commercially available depth of anesthesia monitor
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Eligibility criteria are patients who meet the following conditions.
(1) Patients scheduled for general anesthesia surgery with spinal subarachnoid anesthesia at Tohoku University Hospital
(2) Adult patients aged 20 years or older
(3) Gender is not required.
Key exclusion criteria
(1) Pregnant and lactating women
(2) Patients with Child-Pugh classification C or higher
(3) Patients with central nervous system diseases and psychiatric diseases
(4) Patients who regularly use CNS-acting drugs
(5) Heavy drinkers of alcohol and illegal drugs
(6) Patients who cannot communicate in Japanese
(7) Patients who had an adverse reaction to remimazolam and required a change in anesthetic
(8) Patients who could not be awakened from anesthesia and extubated in the operating room immediately after the completion of surgery
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | KOTOE |
| Middle name | |
| Last name | KAMATA |
Organization
Tohoku University School of Medicine
Division name
Department of Anesthesiology and Perioperative Medicine
Zip code
980-8575
Address
2-1 Seiryo-machi, Aoba-ku, Sendai-shi, Miyagi
TEL
+81-22-717-7321
kotoe.kamata.c3@tohoku.ac.jp
Public contact
Name of contact person
| 1st name | KOTOE |
| Middle name | |
| Last name | KAMATA |
Organization
Tohoku University School of Medicine
Division name
Department of Anesthesiology and Perioperative Medicine
Zip code
980-8575
Address
2-1 Seiryo-machi, Aoba-ku, Sendai-shi, Miyagi
TEL
+81-22-717-7321
Homepage URL
kotoe.kamata.c3@tohoku.ac.jp
Sponsor or person
Institute
Tohoku University
Institute
Department
Personal name
Funding Source
Organization
Tohoku University Center for Gender Equality Promotion
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee Tohoku University Graduate School of Medicine
Address
2-1 Seiryo-machi, Aoba-ku, Sendai-shi, Miyagi
Tel
022-717-8007
med-kenkyo@grp.tohoku.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 06 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2021 | Year | 04 | Month | 08 | Day |
Date of IRB
| 2021 | Year | 04 | Month | 15 | Day |
Anticipated trial start date
| 2021 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2023 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Registration in the UMIN Clinical Trial Registration System
Recruitment of adult patients scheduled for general anesthesia surgery with spinal subarachnoid anesthesia at Tohoku University Hospital (50 patients in total)
1) What we will do in the clinic
Perform spinal subarachnoid anesthesia and confirm that the anesthesia level necessary for surgery is obtained. 2) Perform general anesthesia before induction of general anesthesia. Before induction of general anesthesia, install a general-purpose depth-of-anesthesia monitor and begin EEG recording and depth-of-anesthesia monitoring. Induce general anesthesia with remimazolam and secure the airway. The biometric monitor and EEG data will be automatically transferred to the server in the operating room and stored. Remimazolam administration is discontinued at the end of surgery, and the patient is awakened. If the patient is not awake within 15 minutes after the administration of remimazolam, flumazenil will be administered.
(2) What will be done in this study (additional items to medical practice)
Before induction of general anesthesia, a digital EEG monitor will be additionally installed and recording will begin. The biometric monitor and EEG data obtained during general anesthesia will be stored on a personal computer. Analyze the EEG data (for research purposes). The EEG data recorded by the general anesthesia depth monitor and stored on the personal computer will be analyzed offline (frequency analysis will be performed by Bispectral Analyzer for BIS).
Validation of the general anesthesia depth monitor (for research purposes). Calculate the value of the general anesthesia depth monitor when the power of alpha and beta waves is maximum for each patient.
Management information
Registered date
| 2021 | Year | 06 | Month | 03 | Day |
Last modified on
| 2021 | Year | 06 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050740
